Postmenopausal hormone therapy and risk of cognitive decline in community-dwelling aging women.

@article{Kang2004PostmenopausalHT,
  title={Postmenopausal hormone therapy and risk of cognitive decline in community-dwelling aging women.},
  author={Jae H Kang and Jennifer L Weuve and Francine n Grodstein},
  journal={Neurology},
  year={2004},
  volume={63 1},
  pages={101-7}
}
BACKGROUND A randomized trial of postmenopausal women over age 65 reported increased risks of cognitive decline with 4 years of combined estrogen and progestin treatment. However, questions remain, including the effect of longer duration or of hormone therapy initiated at younger ages. METHODS The Nurses' Health Study is a prospective cohort begun in 1976, comprising 121,700 female nurses who report health information via biennial mailed questionnaires. This substudy includes 13,807… CONTINUE READING